Testing LARS ligament in bone prosthesis replacement
Part of Cancer clinical trials.
This trial is for people with certain cancer-related bone problems who had a specific type of ligament and bone prosthesis replacement done at the study hospital. It looks at how well that LARS ligament and prosthesis approach works for rebuilding the area after cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a cancer diagnosis confirmed in this hospital
- Your cancer is a type (subtype) the study includes
- You previously received an LARS ligament and bone prosthesis replacement here
- You can be any age, and you can be any sex
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at using a 3D-printed bone replacement during surgery to save a limb for certain bone tumors. It may help patients who need part of a bone removed and replaced with a prosthesis made to fit.
This study looks back at patients who had surgery to replace the top part of the thigh bone after a bone sarcoma. Researchers want to understand how well these surgeries worked over time.
This study tests a new, lab-grown ligament made from biological tissue for ACL reconstruction. It may offer a regenerative option for people with a recent ACL tear who need surgery.
This trial collects and follows information about people who had surgery to treat cancer that spread to their long bones (like the femur or humerus) to prevent or fix a broken bone. It may help doctors better understand outcomes after these surgeries and improve future care.
This trial tests a surgical technique to repair a torn ligament in the wrist (the scapholunate ligament) using a part of a nearby tendon. It may be an option for people with this specific wrist injury who meet the health requirements.
This is a study that follows adults who had an ACL tear treated with ACL reconstruction. It helps understand how the surgical device/material performs in real-world care.
Hear when a new Malignant Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.